Clinical trial
Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women
NCT00361595 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00361595 |
|---|---|
| Title | Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women |
| Official title | Open Label Proof of Concept Study of IV Zoledronic Acid (ZA) 5 mg After Forteo in Postmenopausal Women |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | zoledronic acid |
| Enrollment | 35 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Aug 8, 2006 |
| Last update posted | Apr 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: